
EMROK O TABLETS
| MRP | : |
|
| Price | : | ₹2,150.00 |
| You Save | : | ₹502.84 (18.95%) |
1 Packet 4 Tablet
Emrok O Tablet is classified as an ‘antibiotic’ and is primarily utilized to treat bacterial skin and soft tissue infections, including diabetic foot infections and concurrent bacteraemia (the presence of viable bacteria in the bloodstream). It also targets Methicillin-resistant Staphylococcus aureus (MRSA), a significant contributor to antimicrobial resistance (AMR).
Emrok O Tablet contains ‘Levonadifloxacin,’ a bactericidal agent that inhibits bacterial growth and disrupts bacterial replication. Additionally, it acts as a beta-lactamase inhibitor. Beta-lactamases are enzymes produced by bacteria that deactivate the antibiotic, resulting in multi-resistance. Emrok O Tablet exhibits broad-spectrum activity against various pathogens, including Methicillin-resistant Staphylococcus aureus (MRSA), which is a major factor in the increasing rates of antimicrobial resistance (AMR).
Follow your doctor’s instructions when taking Emrok O Tablet. While Emrok O Tablet may cause side effects, not everyone will experience them. Common side effects of Emrok O Tablet include cataracts.